Literature DB >> 18497040

Circulating levels of sex steroids and prolactin in premenopausal women and risk of breast cancer.

Susan E Hankinson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18497040     DOI： 10.1007/978-0-387-69080-3_15

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  16 in total

1.  Unraveling genes, hormones, and breast cancer.

Authors:  Jonine D Figueroa; Louise A Brinton
Journal:  J Natl Cancer Inst       Date:  2012-04-03       Impact factor: 13.506

2.  Interrelationship Between Alcohol Intake and Endogenous Sex-Steroid Hormones on Diabetes Risk in Postmenopausal Women.

Authors:  Rachelle D Rohwer; Simin Liu; Nai-Chieh You; Julie E Buring; JoAnn E Manson; Yiqing Song
Journal:  J Am Coll Nutr       Date:  2015-03-11       Impact factor: 3.169

Review 3.  Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.

Authors:  Hamed Khalili; Punyanganie S de Silva; Ashwin N Ananthakrishnan; Paul Lochhead; Amit Joshi; John J Garber; James R Richter; Jenny Sauk; Andrew T Chan
Journal:  Inflamm Bowel Dis       Date:  2017-07       Impact factor: 5.325

4.  Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.

Authors:  Federico Canzian; David G Cox; V Wendy Setiawan; Daniel O Stram; Regina G Ziegler; Laure Dossus; Lars Beckmann; Hélène Blanché; Aurelio Barricarte; Christine D Berg; Sheila Bingham; Julie Buring; Saundra S Buys; Eugenia E Calle; Stephen J Chanock; Françoise Clavel-Chapelon; John Oliver L DeLancey; W Ryan Diver; Miren Dorronsoro; Christopher A Haiman; Göran Hallmans; Susan E Hankinson; David J Hunter; Anika Hüsing; Claudine Isaacs; Kay-Tee Khaw; Laurence N Kolonel; Peter Kraft; Loïc Le Marchand; Eiliv Lund; Kim Overvad; Salvatore Panico; Petra H M Peeters; Michael Pollak; Michael J Thun; Anne Tjønneland; Dimitrios Trichopoulos; Rosario Tumino; Meredith Yeager; Robert N Hoover; Elio Riboli; Gilles Thomas; Brian E Henderson; Rudolf Kaaks; Heather Spencer Feigelson
Journal:  Hum Mol Genet       Date:  2010-07-15       Impact factor: 6.150

5.  Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer.

Authors:  Jing Pei; Fang Li; Benzhong Wang
Journal:  Tumour Biol       Date:  2013-07-26

6.  Single nucleotide polymorphism 8q24 rs13281615 and risk of breast cancer: meta-analysis of more than 100,000 cases.

Authors:  Wen-Feng Gong; Jian-Hong Zhong; Bang-De Xiang; Liang Ma; Xue-Mei You; Qiu-Ming Zhang; Le-Qun Li
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

7.  IGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-β1 resulting in epithelial to mesenchymal transition.

Authors:  Logan A Walsh; Sashko Damjanovski
Journal:  Cell Commun Signal       Date:  2011-05-02       Impact factor: 5.712

8.  Vitamin D receptor Cdx-2 polymorphism and premenopausal breast cancer risk in southern Pakistani patients.

Authors:  Mehr un Nisa Iqbal; Taseer Ahmed Khan; Syed Amir Maqbool
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

9.  Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts.

Authors:  Hamed Khalili; Ashwin N Ananthakrishnan; Gauree G Konijeti; Leslie M Higuchi; Charles S Fuchs; James M Richter; Shelley S Tworoger; Susan E Hankinson; Andrew T Chan
Journal:  Inflamm Bowel Dis       Date:  2015-06       Impact factor: 5.325

10.  Differential effect of growth factors on invasion and proliferation of endocrine resistant breast cancer cells.

Authors:  Maitham A Khajah; Sanaa Al Saleh; Princy M Mathew; Yunus A Luqmani
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.